Steven Edland
Affiliations: | Neurosciences | University of California, San Diego, La Jolla, CA |
Google:
"Steven Edland"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang X, Jacobs D, Salmon DP, et al. (2023) Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials. International Journal of Statistics in Medical Research. 12: 90-96 |
Edland SD, Llibre-Guerra JJ. (2023) Semorinemab in Mild to Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain. Neurology |
Wang X, Broce I, Qiu Y, et al. (2023) A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Tsiknia AA, Edland SD, Sundermann EE, et al. (2022) Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Molecular Psychiatry |
Levey AI, Qiu D, Zhao L, et al. (2021) A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain : a Journal of Neurology |
Smirnov DS, Salmon DP, Galasko D, et al. (2021) Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study. Neurology |
Smirnov DS, Galasko D, Hiniker A, et al. (2021) Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease. Neurology |
Smirnov DS, Galasko D, Edland SD, et al. (2020) Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology |
Banks SJ, Shifflett B, Berg JL, et al. (2019) Sex-specific composite scales for longitudinal studies of incipient Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 508-514 |
Thomas KR, Edmonds EC, Eppig JS, et al. (2019) MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |